DAVENPORT & Co LLC Raises Stock Holdings in Catalent, Inc. (NYSE:CTLT)

DAVENPORT & Co LLC grew its stake in Catalent, Inc. (NYSE:CTLTGet Rating) by 6.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,786 shares of the company’s stock after buying an additional 169 shares during the period. DAVENPORT & Co LLC’s holdings in Catalent were worth $309,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Pictet Asset Management SA increased its position in Catalent by 2.7% in the fourth quarter. Pictet Asset Management SA now owns 79,266 shares of the company’s stock worth $10,148,000 after buying an additional 2,058 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of Catalent by 365.7% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 12,100 shares of the company’s stock worth $1,549,000 after acquiring an additional 9,502 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Catalent by 5.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 983,199 shares of the company’s stock worth $125,879,000 after acquiring an additional 49,891 shares during the period. Fifth Third Bancorp boosted its stake in shares of Catalent by 34.4% in the fourth quarter. Fifth Third Bancorp now owns 1,641 shares of the company’s stock worth $210,000 after acquiring an additional 420 shares during the period. Finally, Parkside Financial Bank & Trust boosted its stake in shares of Catalent by 127.4% in the fourth quarter. Parkside Financial Bank & Trust now owns 282 shares of the company’s stock worth $36,000 after acquiring an additional 158 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Catalent Trading Down 0.3 %

Shares of CTLT stock opened at $107.63 on Wednesday. Catalent, Inc. has a 1 year low of $86.34 and a 1 year high of $142.64. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.89 and a quick ratio of 2.25. The stock’s 50 day simple moving average is $105.52 and its two-hundred day simple moving average is $103.01. The company has a market cap of $19.29 billion, a PE ratio of 39.00, a price-to-earnings-growth ratio of 1.64 and a beta of 1.32.

Catalent (NYSE:CTLTGet Rating) last issued its quarterly earnings data on Tuesday, May 3rd. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.11. Catalent had a return on equity of 15.07% and a net margin of 10.72%. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the prior year, the business posted $0.78 earnings per share. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. Research analysts predict that Catalent, Inc. will post 3.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. StockNews.com assumed coverage on Catalent in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft dropped their price objective on Catalent from $129.00 to $110.00 and set a “hold” rating for the company in a research note on Tuesday, April 12th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Catalent has a consensus rating of “Moderate Buy” and a consensus price target of $142.86.

Catalent Company Profile

(Get Rating)

Catalent, Inc, together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services.

Read More

Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent, Inc. (NYSE:CTLTGet Rating).

Institutional Ownership by Quarter for Catalent (NYSE:CTLT)

Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.